ATAGI 2023 Annual Statement on Immunisation

Authors

  • Australian Technical Advisory Group on Immunisation (ATAGI) secretariat, Immunisation Branch, Australian Government
  • Madeline Valeri National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Shireen Durrani National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Catherine Tran National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Clayton Chiu [1] National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Sydney, New South Wales, Australia [2] Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney
  • Kristine K Macartney [1] National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Sydney, New South Wales, Australia [2] Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney [3] Australian Technical Advisory Group on Immunisation, Department of Health, Australian Government, Canberra, Australian Capital Territory, Australia
  • Michelle L Giles [1] Australian Technical Advisory Group on Immunisation, Department of Health, Australian Government, Canberra, Australian Capital Territory, Australia [2] Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia [3] Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia
  • Nigel W Crawford [1] Australian Technical Advisory Group on Immunisation, Department of Health, Australian Government, Canberra, Australian Capital Territory, Australia [2] Department of General Paediatrics, Royal Children’s Hospital, Melbourne, Victoria, Australia [3] Infection and Immunity, Murdoch Children’s Research Institute and University of Melbourne, Victoria, Australia

DOI:

https://doi.org/10.33321/cdi.2023.47.42

Keywords:

immunisation, vaccine preventable diseases, Australia

Abstract

The Australian Technical Advisory Group on Immunisation (ATAGI) 2023 Annual Statement on Immunisation is the third publication in this series. It highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases (VPDs) in Australia in 2022. It also signals ATAGI’s priority actions for addressing key issues for 2023 and beyond.

Downloads

Download data is not yet available.

References

Australian Government Department of Health and Aged Care. Japanese encephalitis virus situation declared a Communicable Disease Incident of National Significance. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 4 March 2022. Available from: https://www.health.gov.au/news/japanese-encephalitis-virus-situation-declared-a-communicable-disease-incident-of-national-significance.

Australian Government Department of Health and Aged Care. ATAGI clinical guidance on Japanese encephalitis virus vaccines. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 23 December 2022. Available from: https://www.health.gov.au/health-alerts/japanese-encephalitis-virus-jev/atagi-clinical-guidance-on-japanese-encephalitis-virus-vaccines.

World Health Organization (WHO). Disease outbreak news. Multi-country monkeypox outbreak in non-endemic countries. [Internet.] Geneva: WHO; 21 May 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385.

Australian Government Department of Health and Aged Care. Chief Medical Officer’s statement declaring monkeypox a Communicable Disease Incident of National Significance. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 28 July 2022. Available from: https://www.health.gov.au/news/chief-medical-officers-statement-declaring-monkeypox-a-communicable-disease-incident-of-national-significance.

Australian Government Department of Health and Aged Care. ATAGI clinical guidance on vaccination against Monkeypox. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 12 December 2022. Available from: https://www.health.gov.au/resources/publications/atagi-clinical-guidance-on-vaccination-against-monkeypox.

Global Polio Eradication Initiative (GPEI). Outbreak Countries [Internet.] Geneva: WHO, GPEI. Available from: https://polioeradication.org/where-we-work/polio-outbreak-countries/.

WHO. Nearly 40 million children are dangerously susceptible to growing measles threat. [Internet.] Geneva: WHO; 23 November 2022. Available from: https://www.who.int/news/item/23-11-2022-nearly-40-million-children-are-dangerously-susceptible-to-growing-measles-threat.

Australian Government Department of Health and Aged Care. ATAGI clinical guidance for COVID-19 vaccine providers. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 2021. Available from: https://www.health.gov.au/our-work/covid-19-vaccines/advice-for-providers/clinical-guidance.

Australian Government Department of Health and Aged Care. COVID-19 vaccination – Provider resources [Internet.] Canberra: Australian Government Department of Health and Aged Care; 6 May 2021. Available from: https://www.health.gov.au/resources/collections/covid-19-vaccination-provider-resources.

Australian Government Department of Health and Aged Care. COVID-19 vaccination – Patient resources. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 6 May 2021. Available from: https://www.health.gov.au/resources/collections/covid-19-vaccination-patient-resources.

Therapeutic Goods Administration (TGA). COVID-19 vaccines undergoing evaluation. [Internet.] Canberra: Australian Government Department of Health and Aged Care, TGA; updated 24 April 2023. Available from: https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccines-undergoing-evaluation.

Australian Government Department of Health and Aged Care. ATAGI update following weekly COVID-19 meeting – 12 January 2022. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 17 January 2022. Available from: https://www.health.gov.au/news/atagi-update-following-weekly-covid-19-meeting-12-january-2022.

Australian Government Department of Health and Aged Care. ATAGI statement on the use of Novavax COVID-19 vaccine (Nuvaxovid). [Internet.] Canberra: Australian Government Department of Health and Aged Care; 24 January 2022. Available from: https://www.health.gov.au/news/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid.

Australian Government Department of Health and Aged Care. ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 3 February 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-for-use-of-pfizer-covid-19-vaccine-as-a-booster-dose-in-adolescents-aged-16-17-years.

Australian Government Department of Health and Aged Care. ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 23 February 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-the-use-of-spikevax-moderna-covid-19-vaccine-in-children-aged-6-to-11-years.

Australian Government Department of Health and Aged Care. ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 25 March 2022. Available from: https://www.health.gov.au/news/atagi-statement-on-recommendations-on-a-winter-booster-dose-of-covid-19-vaccine.

Australian Government Department of Health and Aged Care. Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 25 May 2022. Available from: https://www.health.gov.au/news/expanded-atagi-recommendations-on-winter-covid-19-booster-doses-for-people-at-increased-risk-of-severe-covid-19.

Australian Government Department of Health and Aged Care. ATAGI recommendations on first booster dose in adolescents aged 12-15 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 9 June 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-first-booster-dose-in-adolescents-aged-12-15-years.

Australian Government Department of Health and Aged Care. ATAGI updated recommendations for a winter dose of COVID-19 vaccine. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 7 July 2022. Available from: https://www.health.gov.au/news/atagi-updated-recommendations-for-a-winter-dose-of-covid-19-vaccine.

Australian Government Department of Health and Aged Care. ATAGI recommendations on COVID-19 vaccine use in children aged 6 months to <5 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 3 August 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-covid-19-vaccine-use-in-children-aged-6-months-to.

Australian Government Department of Health and Aged Care. Novavax vaccine for adolescents aged 12–17 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 25 August 2022. Available from: https://www.health.gov.au/news/novavax-vaccine-for-adolescents-aged-12-17-years.

Australian Government Department of Health and Aged Care. ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 12 September 2022. Available from: https://www.health.gov.au/news/atagi-statement-on-use-of-the-moderna-bivalent-originalomicron-vaccine.

Australian Government Department of Health and Aged Care. ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 24 October 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-for-a-booster-dose-of-the-paediatric-pfizer-covid-19-vaccine-in-children-aged-5-to-11-years.

Australian Government Department of Health and Aged Care. ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 14 November 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-pfizer-bivalent-originalomicron-ba1-covid-19-vaccine.

Australian Government Department of Health and Aged Care. ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 14 November 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-pfizer-covid-19-vaccine-for-children-aged-6-months-to-4-years.

TGA. COVID-19 vaccine safety reports. [Internet.] Canberra: Australian Government Department of Health and Aged Care, TGA. Available from: https://www.tga.gov.au/news/covid-19-vaccine-safety-reports.

AusVaxSafety. COVID-19 vaccines. [Internet.] Sydney: National Centre for Immunisation Research and Surveillance, AusVaxSafety; 2021. Available from: https://ausvaxsafety.org.au/safety-data/covid-19-vaccines.

Australian Government Department of Health and Aged Care. COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 23 September 2022. Available from: https://www.health.gov.au/resources/publications/covid-19-vaccination-guidance-on-myocarditis-and-pericarditis-after-covid-19-vaccines.

Australian Government Department of Health and Aged Care. COVID-19 Vaccine Claims Scheme. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 3 April 2023. Available from: https://www.health.gov.au/our-work/covid-19-vaccine-claims-scheme.

Australian Government Department of Health and Aged Care. AISR – 2022 national influenza season summary. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 20 December 2022. Available from: https://www.health.gov.au/resources/publications/aisr-2022-national-influenza-season-summary.

Gidding HF, Burgess MA, Gilbert GL. Diphtheria in Australia, recent trends and future prevention strategies. Commun Dis Intell. 2000;24(6):165–7.

Australian Government Department of Health and Aged Care. COVID-19 vaccine rollout update – 22 December 2022. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 23 December 2022. Available from: https://www.health.gov.au/resources/publications/covid-19-vaccine-rollout-update-22-december-2022.

Victoria State Government Department of Health. Victorian Pharmacist-Administered Vaccination Program Guidelines. [Internet.] Melbourne: Victoria State Government Department of Health; 3 October 2022. Available from: https://www.health.vic.gov.au/immunisation/victorian-pharmacist-administered-vaccination-program-guidelines.

New South Wales Government Department of Health (NSW Health). Pharmacist initiation and administration of vaccines. [Internet.] Sydney: NSW Health; 17 April 2023. Available from: https://www.health.nsw.gov.au/immunisation/Pages/pharmacist-vaccination-expansion.aspx.

TGA. Report a problem or side effect. [Webpage.] Canberra: Australian Government Department of Health and Aged Care, TGA. Available from: https://www.tga.gov.au/reporting-problems.

AusvaxSafety. Influenza vaccines. [Internet.] Sydney: NCIRS, AusVaxSafety; 2022. Available from: https://ausvaxsafety.org.au/safety-data/influenza-vaccine.

Islam N, Lau C, Leeb A, Mills D, Furuya-Kanamori L. Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. Hum Vaccin Immunother. 2022;18(1):2020573. doi: https://doi.org/10.1080/21645515.2021.2020573.

AusVaxSafety. Mpox (monkeypox) vaccine. [Internet.] Sydney: NCIRS, AusVaxSafety; 2022. Available from: https://ausvaxsafety.org.au/vaccine-safety-data/mpox-monkeypox-vaccine.

Australian Government Department of Health and Aged Care. Operation COVID Shield COVID-19 Vaccine Sentiment Summaries. [Internet.] Canberra: Australian Government Department of Health and Aged Care. Available from: https://www.health.gov.au/resources/collections/operation-covid-shield-covid-19-vaccine-sentiment-summaries.

Australian Government Department of Health. ATAGI strategic intent. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 9 January 2018. Available from: https://www.health.gov.au/resources/publications/atagi-strategic-intent.

Downloads

Published

27/07/23

How to Cite

Australian Technical Advisory Group on Immunisation (ATAGI) secretariat, Immunisation Branch, Australian Government, Madeline Valeri, Shireen Durrani, Catherine Tran, Clayton Chiu, Kristine K Macartney, Michelle L Giles, and Nigel W Crawford. 2023. “ATAGI 2023 Annual Statement on Immunisation”. Communicable Diseases Intelligence 47 (July). https://doi.org/10.33321/cdi.2023.47.42.

Issue

Vol. 47 (2023)

Section

Notice to readers

Categories

License

Copyright (c) 2023 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>